EUVIMEDEUVIMED entdecken
Crossref

Condensation of cellular prion protein promotes renal fibrosis through the TBK1-IRF3 signaling axis

Tantan Long iD, Yumei Lu iD, Yuanyuan Ma iD, Yandong Song iD, Xiaoping Yi, Xiaomei Chen, Miaomiao Zhou, Jingyi Ma, Jiayuan Chen, Zhuoliang Liu, Fengxin Zhu, Zheng Hu und 6 weitere

Science Translational Medicine · 16.04.2025 · 17 (794)

DOI: 10.1126/scitranslmed.adj9095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 16.04.2025. Verfasst von Tantan Long und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Guangdong Provincial Key Laboratory of Renal Fa…. Hauptthemen laut MEDLINE: Signal Transduction, Protein Serine-Threonine Kinases, Interferon Regulatory Factor-3, Kidney. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular prion protein (PrP C ), known for its pathological isoform in prion diseases such as Creutzfeldt-Jakob disease, is primarily expressed in the nervous system but has also been detected in the blood and urine of individuals with renal dysfunction. However, the role of PrP C in the development of renal disease is unexplored. Here, we showed that PrP C was up-regulated in fibrotic renal lesions in biopsies from patients with chronic kidney disease (CKD), predominantly in proximal tubular epithelial cells (PTECs). Furthermore, renal expression of PrP C was positively correlated with the severity of renal failure and the decline in estimated glomerular filtration rate in patients with CKD. In mice, tubular-specific deletion of PrP C mitigated renal fibrosis induced by unilateral ureteral obstruction (UUO) or unilateral ischemia-reperfusion injury (UIRI). Mechanistically, PrP C was up-regulated by transforming growth factor–β1–suppressor of mothers against decapentaplegic 3 signaling. PrP C activated TANK binding kinase 1 (TBK1)–interferon regulatory factor 3 (IRF3) signaling through its capacity for liquid-liquid phase separation, which promoted a profibrotic response in PTECs and fibroblasts. Treating mice with amlexanox, a US Food and Drug Administration–approved inhibitor of TBK1, either before the onset of renal fibrosis (in UUO and UIRI models) or after its establishment (in adenine- and aristolochic acid–induced CKD models), mitigated worsening of renal fibrosis and renal function. Collectively, our findings uncovered a mechanism involving phase separation of PrP C underlying renal fibrosis and support further study of the PrP C -TBK1-IRF3 axis as a potential therapeutic target for CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionProtein Serine-Threonine KinasesInterferon Regulatory Factor-3KidneyPrion ProteinsAnimalsFibrosisHumansMiceRenal Insufficiency, ChronicMaleMice, Inbred C57BLEpithelial CellsUreteral ObstructionReperfusion Injury

Substanzen

Protein Serine-Threonine KinasesInterferon Regulatory Factor-3Prion ProteinsTBK1 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangdong Provincial Institute of Nephrology, Nanfang…
  • Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), State Key Laboratory of Experimental Hematology,…
  • Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Hunan Province Key Laboratory of Tumor Cellular and Molecular Pathology, Cancer Research Institute, School of Basic Medical Sciences,…
  • Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Guangzhou Institute of Cancer Research, Affiliated Cancer Hospital, Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou 510095, China.
  • Biobank of Peking University First Hospital, Peking University First Hospital, Beijing 100034, China.

ORCID-Profile: Tantan Long, Yumei Lu, Yuanyuan Ma, Yandong Song, Fan Fan Hou, Lirong Zhang, Yupeng Chen, Jing Nie

Zitieren

APA

Long, T., Lu, Y., Ma, Y., Song, Y., Yi, X., Chen, X., Zhou, M., Ma, J., Chen, J., Liu, Z., Zhu, F., Hu, Z., Zhou, Z., Li, C., Hou, F. F., Zhang, L., Chen, Y., & Nie, J. (2025). Condensation of cellular prion protein promotes renal fibrosis through the TBK1-IRF3 signaling axis. Science Translational Medicine, 17(794). https://doi.org/10.1126/scitranslmed.adj9095

Vancouver

Long T, Lu Y, Ma Y, Song Y, Yi X, Chen X, et al. Condensation of cellular prion protein promotes renal fibrosis through the TBK1-IRF3 signaling axis. Science Translational Medicine. 2025;17(794). doi:10.1126/scitranslmed.adj9095

BibTeX
@article{Long2025,
  author = {Long, Tantan and Lu, Yumei and Ma, Yuanyuan and Song, Yandong and Yi, Xiaoping and Chen, Xiaomei and Zhou, Miaomiao and Ma, Jingyi and Chen, Jiayuan and Liu, Zhuoliang and Zhu, Fengxin and Hu, Zheng and Zhou, Zhanmei and Li, Chaoyang and Hou, Fan Fan and Zhang, Lirong and Chen, Yupeng and Nie, Jing},
  title = {Condensation of cellular prion protein promotes renal fibrosis through the TBK1-IRF3 signaling axis},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {794},
  doi = {10.1126/scitranslmed.adj9095}
}
Kostenlos starten →